PAMS
VERA icon

Pictet Asset Management (Switzerland)’s Vera Therapeutics VERA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$14.8M Buy
+919,352
New +$8.3M 0.02% 538

Other funds holding VERA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s VERA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) opened a new position in Vera Therapeutics (VERA) in Q2 2023: 919,352 shares worth $14.8M. The stake represents 0.02% of the portfolio and ranks #538 among its holdings.

76 funds tracked by Wall St. Rank hold VERA as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 919,352 shares of Vera Therapeutics worth $14.8M as of Q2 2023.
  • Vera Therapeutics was a new Pictet Asset Management (Switzerland) position in Q2 2023.
  • Vera Therapeutics made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #538 holding.
  • 76 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.